Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India

Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India

During September–December 2020, we conducted a multicenter retrospective study across India to evaluate epidemiology and outcomes among cases of coronavirus disease (COVID-19)–associated mucormycosis (CAM). Among 287 mucormycosis patients, 187 (65.2%) had CAM; CAM prevalence was 0.27% among hospita...

Full description

Bibliographic Details
Main Authors: Atul Patel, Ritesh Agarwal, Shivaprakash M. Rudramurthy, Manoj Shevkani, Immaculata Xess, Ratna Sharma, Jayanthi Savio, Nandini Sethuraman, Surabhi Madan, Prakash Shastri, Deepak Thangaraju, Rungmei Marak, Karuna Tadepalli, Pratik Savaj, Ayesha Sunavala, Neha Gupta, Tanu Singhal, Valliappan Muthu, Arunaloke Chakrabarti
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-09-01
Series:Emerging Infectious Diseases
Subjects:
respiratory infections
severe acute respiratory syndrome coronavirus 2
SARS-CoV-2
SARS
COVID-19
coronavirus disease
Online Access:https://wwwnc.cdc.gov/eid/article/27/9/21-0934_article

Internet

https://wwwnc.cdc.gov/eid/article/27/9/21-0934_article

Similar Items